Direct in vivo gene transfer to urological organs

James J. Yoo, Shay Soker, Lee F. Lin, Kathryn Mehegan, Paul D. Guthrie, Anthony Atala

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: Patients with urological disorders may benefit from gene based therapy. We investigated the feasibility of delivering exogenous genes into urological tissues in vivo using direct in vivo electrotransfection. Materials and Methods: Gene transfer to rat kidneys, testes and bladders was accomplished via direct local injection of pGL3/luciferase and β- galactosidase reporter gene constructs, followed by an electrical pulse ranging from 55 to 115 msec. at 100 V. Direct injection of deoxyribonucleic acid without an electrical pulse served as the control. The transfected and nontransfected organs were retrieved and analyzed by luciferase activity assay, histochemical and immunocytochemical staining for β-galactosidase, and reverse transcription polymerase chain reaction with primers specific for β-galactosidase messenger ribonucleic acid. Results: There was significant luciferase activity 1, 3 and 5 days after direct in vivo electrotransfection in kidneys and testes, and after 3, 5, 7 and 10 days in bladders. Positive β-galactosidase enzyme activity and β-galactosidase immunoreactivity were observed in the transfected renal tubular cells, testicular interstitial and germ cells, and uroepithelial bladder layer. Reverse transcription-polymerase chain reaction products of the transfected organs were noted, indicating the successful transcription of messenger ribonucleic acid. Conclusions: This study demonstrates that direct in vivo electrotransfection is a feasible method of transient gene delivery into intact urological organs. Its apparent safety and relative simplicity suggest that direct in vivo electrotransfection may be useful clinically.

Original languageEnglish
Pages (from-to)1115-1118
Number of pages4
JournalJournal of Urology
Volume162
Issue number3 II
DOIs
StatePublished - Sep 1 1999
Externally publishedYes

Fingerprint

Galactosidases
Luciferases
Urinary Bladder
Genes
Kidney
Reverse Transcription
Testis
RNA
Polymerase Chain Reaction
Injections
Leydig Cells
Reporter Genes
Germ Cells
Genetic Therapy
Staining and Labeling
Safety
DNA
Enzymes

Keywords

  • Bladder
  • Electroporation
  • Gene transfer
  • Kidney
  • Testis

ASJC Scopus subject areas

  • Urology

Cite this

Yoo, J. J., Soker, S., Lin, L. F., Mehegan, K., Guthrie, P. D., & Atala, A. (1999). Direct in vivo gene transfer to urological organs. Journal of Urology, 162(3 II), 1115-1118. https://doi.org/10.1016/S0022-5347(01)68088-1

Direct in vivo gene transfer to urological organs. / Yoo, James J.; Soker, Shay; Lin, Lee F.; Mehegan, Kathryn; Guthrie, Paul D.; Atala, Anthony.

In: Journal of Urology, Vol. 162, No. 3 II, 01.09.1999, p. 1115-1118.

Research output: Contribution to journalArticle

Yoo, JJ, Soker, S, Lin, LF, Mehegan, K, Guthrie, PD & Atala, A 1999, 'Direct in vivo gene transfer to urological organs', Journal of Urology, vol. 162, no. 3 II, pp. 1115-1118. https://doi.org/10.1016/S0022-5347(01)68088-1
Yoo JJ, Soker S, Lin LF, Mehegan K, Guthrie PD, Atala A. Direct in vivo gene transfer to urological organs. Journal of Urology. 1999 Sep 1;162(3 II):1115-1118. https://doi.org/10.1016/S0022-5347(01)68088-1
Yoo, James J. ; Soker, Shay ; Lin, Lee F. ; Mehegan, Kathryn ; Guthrie, Paul D. ; Atala, Anthony. / Direct in vivo gene transfer to urological organs. In: Journal of Urology. 1999 ; Vol. 162, No. 3 II. pp. 1115-1118.
@article{bfe06d72151e4a68b30106c9b62b3413,
title = "Direct in vivo gene transfer to urological organs",
abstract = "Purpose: Patients with urological disorders may benefit from gene based therapy. We investigated the feasibility of delivering exogenous genes into urological tissues in vivo using direct in vivo electrotransfection. Materials and Methods: Gene transfer to rat kidneys, testes and bladders was accomplished via direct local injection of pGL3/luciferase and β- galactosidase reporter gene constructs, followed by an electrical pulse ranging from 55 to 115 msec. at 100 V. Direct injection of deoxyribonucleic acid without an electrical pulse served as the control. The transfected and nontransfected organs were retrieved and analyzed by luciferase activity assay, histochemical and immunocytochemical staining for β-galactosidase, and reverse transcription polymerase chain reaction with primers specific for β-galactosidase messenger ribonucleic acid. Results: There was significant luciferase activity 1, 3 and 5 days after direct in vivo electrotransfection in kidneys and testes, and after 3, 5, 7 and 10 days in bladders. Positive β-galactosidase enzyme activity and β-galactosidase immunoreactivity were observed in the transfected renal tubular cells, testicular interstitial and germ cells, and uroepithelial bladder layer. Reverse transcription-polymerase chain reaction products of the transfected organs were noted, indicating the successful transcription of messenger ribonucleic acid. Conclusions: This study demonstrates that direct in vivo electrotransfection is a feasible method of transient gene delivery into intact urological organs. Its apparent safety and relative simplicity suggest that direct in vivo electrotransfection may be useful clinically.",
keywords = "Bladder, Electroporation, Gene transfer, Kidney, Testis",
author = "Yoo, {James J.} and Shay Soker and Lin, {Lee F.} and Kathryn Mehegan and Guthrie, {Paul D.} and Anthony Atala",
year = "1999",
month = "9",
day = "1",
doi = "10.1016/S0022-5347(01)68088-1",
language = "English",
volume = "162",
pages = "1115--1118",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3 II",

}

TY - JOUR

T1 - Direct in vivo gene transfer to urological organs

AU - Yoo, James J.

AU - Soker, Shay

AU - Lin, Lee F.

AU - Mehegan, Kathryn

AU - Guthrie, Paul D.

AU - Atala, Anthony

PY - 1999/9/1

Y1 - 1999/9/1

N2 - Purpose: Patients with urological disorders may benefit from gene based therapy. We investigated the feasibility of delivering exogenous genes into urological tissues in vivo using direct in vivo electrotransfection. Materials and Methods: Gene transfer to rat kidneys, testes and bladders was accomplished via direct local injection of pGL3/luciferase and β- galactosidase reporter gene constructs, followed by an electrical pulse ranging from 55 to 115 msec. at 100 V. Direct injection of deoxyribonucleic acid without an electrical pulse served as the control. The transfected and nontransfected organs were retrieved and analyzed by luciferase activity assay, histochemical and immunocytochemical staining for β-galactosidase, and reverse transcription polymerase chain reaction with primers specific for β-galactosidase messenger ribonucleic acid. Results: There was significant luciferase activity 1, 3 and 5 days after direct in vivo electrotransfection in kidneys and testes, and after 3, 5, 7 and 10 days in bladders. Positive β-galactosidase enzyme activity and β-galactosidase immunoreactivity were observed in the transfected renal tubular cells, testicular interstitial and germ cells, and uroepithelial bladder layer. Reverse transcription-polymerase chain reaction products of the transfected organs were noted, indicating the successful transcription of messenger ribonucleic acid. Conclusions: This study demonstrates that direct in vivo electrotransfection is a feasible method of transient gene delivery into intact urological organs. Its apparent safety and relative simplicity suggest that direct in vivo electrotransfection may be useful clinically.

AB - Purpose: Patients with urological disorders may benefit from gene based therapy. We investigated the feasibility of delivering exogenous genes into urological tissues in vivo using direct in vivo electrotransfection. Materials and Methods: Gene transfer to rat kidneys, testes and bladders was accomplished via direct local injection of pGL3/luciferase and β- galactosidase reporter gene constructs, followed by an electrical pulse ranging from 55 to 115 msec. at 100 V. Direct injection of deoxyribonucleic acid without an electrical pulse served as the control. The transfected and nontransfected organs were retrieved and analyzed by luciferase activity assay, histochemical and immunocytochemical staining for β-galactosidase, and reverse transcription polymerase chain reaction with primers specific for β-galactosidase messenger ribonucleic acid. Results: There was significant luciferase activity 1, 3 and 5 days after direct in vivo electrotransfection in kidneys and testes, and after 3, 5, 7 and 10 days in bladders. Positive β-galactosidase enzyme activity and β-galactosidase immunoreactivity were observed in the transfected renal tubular cells, testicular interstitial and germ cells, and uroepithelial bladder layer. Reverse transcription-polymerase chain reaction products of the transfected organs were noted, indicating the successful transcription of messenger ribonucleic acid. Conclusions: This study demonstrates that direct in vivo electrotransfection is a feasible method of transient gene delivery into intact urological organs. Its apparent safety and relative simplicity suggest that direct in vivo electrotransfection may be useful clinically.

KW - Bladder

KW - Electroporation

KW - Gene transfer

KW - Kidney

KW - Testis

UR - http://www.scopus.com/inward/record.url?scp=0032829319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032829319&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)68088-1

DO - 10.1016/S0022-5347(01)68088-1

M3 - Article

VL - 162

SP - 1115

EP - 1118

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3 II

ER -